Full Text View
Tabular View
No Study Results Posted
Related Studies
Mycophenolate for Pulmonary Sarcoidosis
This study has been terminated.
Study NCT00262132   Information provided by Medical University of South Carolina
First Received: December 5, 2005   Last Updated: January 4, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Sarcoidosis
Additional conditions recognized in this trial
Sarcoidosis
Sarcoidosis, Pulmonary
More general conditions related to this trial
Lung Diseases
Lung Diseases, Interstitial
Lymphatic Diseases
Lymphoproliferative Disorders
Respiratory Tract Diseases
Interventions listed in this trial
Mycophenolate
Additional drug interventions recognized in this trial
Mycophenolate mofetil
Mycophenolic Acid
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Medical University of South Carolina
Hoffmann-La Roche


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services